{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:21:30Z","timestamp":1775683290142,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Grunenthal GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s13318-017-0400-7","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T02:19:30Z","timestamp":1484187570000},"page":"801-814","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients"],"prefix":"10.1007","volume":"42","author":[{"given":"Roberta","family":"Bursi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Piana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Grevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dymphy","family":"Huntjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmgard","family":"Boesl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"issue":"9","key":"400_CR1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-1241.2009.02089.x","volume":"63","author":"RW Johnson","year":"2009","unstructured":"Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. Int J Clin Pract. 2009;63(9):1386\u201391.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"400_CR2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"400_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38\u201347.","journal-title":"Epidemiol Infect"},{"key":"400_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"issue":"1 Suppl 1","key":"400_CR5","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Gnann Jr JW, Oaklander AL, et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(1 Suppl 1):S37\u201344.","journal-title":"J Pain"},{"key":"400_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.","journal-title":"BMC Med"},{"issue":"4","key":"400_CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","volume":"20","author":"K Lukas","year":"2012","unstructured":"Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss. 2012;20(4):441\u201351.","journal-title":"Z Gesundh Wiss"},{"issue":"11","key":"400_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40266-012-0014-3","volume":"29","author":"S Nalamachu","year":"2012","unstructured":"Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29(11):863\u20139.","journal-title":"Drugs Aging"},{"issue":"3 Suppl","key":"400_CR9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"400_CR10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113\u201388.","journal-title":"Eur J Neurol"},{"issue":"2","key":"400_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162\u201373.","journal-title":"Lancet Neurol"},{"key":"400_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/JPR.S99231","volume":"9","author":"OA de Le\u00f3n-Casasola","year":"2016","unstructured":"de Le\u00f3n-Casasola OA, Mayoral V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9:67\u201379.","journal-title":"J Pain Res"},{"issue":"1","key":"400_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40122-015-0034-x","volume":"4","author":"ML Navez","year":"2015","unstructured":"Navez ML, Monella C, B\u00f6sl I, et al. 5% lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerability. Pain Ther. 2015;4(1):1\u201315.","journal-title":"Pain Ther"},{"issue":"3","key":"400_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-197803030-00001","volume":"3","author":"NL Benowitz","year":"1978","unstructured":"Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet. 1978;3(3):177\u2013201.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"400_CR15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0002-8703(89)90862-4","volume":"117","author":"NA Estes 3rd","year":"1989","unstructured":"Estes NA 3rd, Manolis AS, Greenblatt DJ, et al. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion. Am Heart J. 1989;117(5):1060\u20134.","journal-title":"Am Heart J"},{"issue":"7","key":"400_CR16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2165\/00003088-200342070-00004","volume":"42","author":"G J\u00fcrgens","year":"2003","unstructured":"J\u00fcrgens G, Graudal NA, Kampmann JP. Therapeutic drug monitoring of antiarrhythmic drugs. Clin Pharmacokinet. 2003;42(7):647\u201364.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"400_CR17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-8703(74)90287-7","volume":"88","author":"RG Burney","year":"1974","unstructured":"Burney RG, DiFazio CA, Peach MJ, Silvester MJ. Anti-arrhythmic effects of lidocaine metabolites. Am Heart J. 1974;88(6):765\u20139.","journal-title":"Am Heart J"},{"issue":"22","key":"400_CR18","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/ajhp\/59.22.2215","volume":"59","author":"AR Gammaitoni","year":"2002","unstructured":"Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continuously applied lidocaine patches 5%. Am J Health Syst Pharm. 2002;59(22):2215\u201320.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"400_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1345\/aph.1A185","volume":"36","author":"AR Gammaitoni","year":"2002","unstructured":"Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of Lidocaine patch 5% with extended dosing. Ann Pharmacother. 2002;36(2):236\u201340.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"400_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jps.10133","volume":"91","author":"BJ Campbell","year":"2002","unstructured":"Campbell BJ, Rowbotham M, Davies PS, et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia and patients with acute herpes zoster. J Pharm Sci. 2002;91(5):1343\u201350.","journal-title":"J Pharm Sci"},{"issue":"6","key":"400_CR21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2125.1991.tb03971.x","volume":"32","author":"L Aarons","year":"1991","unstructured":"Aarons L. Population pharmacokinetics: theory and practice. Br J Clin Pharmacol. 1991;32(6):669\u201370.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"400_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00044011-200929060-00003","volume":"29","author":"A Binder","year":"2009","unstructured":"Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig. 2009;29(6):393\u2013408.","journal-title":"Clin Drug Investig"},{"issue":"5","key":"400_CR23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1185\/03007990902901368","volume":"25","author":"G Hans","year":"2009","unstructured":"Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin. 2009;25(5):1295\u2013305.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"400_CR24","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/carcin\/15.10.2287","volume":"15","author":"MS Bryant","year":"1994","unstructured":"Bryant MS, Simmons HF, Harrell RE, et al. 2,6-Dimethylaniline\u2014hemoglobin adducts from lidocaine in humans. Carcinogenesis. 1994;15(10):2287\u201390.","journal-title":"Carcinogenesis"},{"issue":"4","key":"400_CR25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1208\/s12248-011-9304-7","volume":"13","author":"D Morris","year":"2011","unstructured":"Morris D, Podolski J, Kirsch A, et al. Population pharmacokinetics of telapristone (CDB-4124) and its active monodemethylated metabolite CDB-4453, with a mixture model for total clearance. AAPS J. 2011;13(4):665\u201373.","journal-title":"AAPS J"},{"issue":"1","key":"400_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2125.2001.01301.x","volume":"51","author":"AD Huitema","year":"2001","unstructured":"Huitema AD, Mathot RA, Tibben M, et al. Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy. Br J Clin Pharmacol. 2001;51(1):61\u201370.","journal-title":"Br J Clin Pharmacol"},{"key":"400_CR27","unstructured":"Summary of product characteristics. UK SPC lidocaine 5% medicated plaster. Gr\u00fcnenthal Ltd, Uxbridge, Middlesex, UK, 13 Nov 2014."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-017-0400-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-017-0400-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-017-0400-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T19:13:22Z","timestamp":1718997202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-017-0400-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1007\/s13318-017-0400-7","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}